Hongfeng Chen
725 South Wanping Road
Shanghai, 200032, China
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Effects of the efficacy of the Yi Shen Tiao Gan formula on aromatase inhibitor associated musculoskeletal syndrome: a randomized controlled trial.
Journal: Frontiers in pharmacology
Published: June 03, 2025
SOCS3: An Immunological Biomarker Offering Potential Therapeutic Targets for Malignant Tumors.
Journal: Biological procedures online
Published: April 13, 2025
Diagnosis of non-puerperal mastitis based on "whole tongue" features: non-invasive biomarker mining and diagnostic model construction.
Journal: Frontiers in cellular and infection microbiology
Published: March 30, 2025
Yi Shen Tiao Gan decoction alleviates aromatase inhibitor-related bone loss by promoting H-type vessel formation.
Journal: Translational oncology
Published: August 31, 2024
Breast Cancer Bone Metastasis: Novel Prognostic Biomarkers Identified.
Journal: Phenomics (Cham, Switzerland)
Published: March 22, 2024
A cohort study of prolactin and non-puerperal mastitis using real world data.
Journal: Scientific reports
Published: February 02, 2024
Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
Journal: Medicine
Published: September 01, 2023
Differences and significance of peripheral blood interleukin-6 expression between patients with granulomatous lobular mastitis and those with benign breast tumors.
Journal: Frontiers in medicine
Published: August 06, 2023
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss.
Construction and validation of a risk prediction model for aromatase inhibitor-associated bone loss.
Journal: Frontiers in oncology
Published: March 09, 2023
Association between endocrine therapy and cognitive decline in breast cancer based on propensity score matching.
Journal: Frontiers in medicine
Published: December 27, 2022
Efficacy and safety of CDK4/6 inhibitors combined with endocrine therapy versus endocrine therapy alone in hormone receptor-positive, HER2-negative, advanced breast cancer: a systematic review and meta-analysis.
Journal: Annals of palliative medicine
Published: October 20, 2022
Management of Intraductal Papilloma of the Breast Diagnosed on Core Needle Biopsy: Latest Controversies.
Journal: Phenomics (Cham, Switzerland)
Published: January 25, 2022
Last Updated: 09/26/2026